Miach Orthopaedics has developed the BEAR® Implant, a medical device that utilizes a patient's own blood to promote the healing of torn anterior cruciate ligaments (ACLs) by facilitating new tissue growth between the torn ends. This technology addresses the challenge of ACL injuries by providing a biological scaffold that is gradually replaced by the patient's healed ligament.
Funding
$92.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Anterior cruciate ligament (ACL) tears are a common knee injury, and traditional treatments often involve reconstruction using grafts, which can have limitations and potential donor site morbidity. Current methods may not always fully restore native knee biomechanics or result in complete healing of the torn ACL.
Solution
Miach Orthopaedics offers the BEAR® (Bridge-Enhanced ACL Repair) Implant, a novel medical device designed to facilitate the healing of torn ACLs using the patient's own blood. The BEAR Implant acts as a biological scaffold placed between the torn ends of the ACL, promoting new tissue growth and bridging the gap. Over time, the implant is resorbed and replaced by the patient's own healed ACL tissue, potentially restoring native knee kinematics. This approach aims to provide a less invasive alternative to traditional ACL reconstruction, reducing the need for grafts and promoting natural healing.
Target Audience
The primary target audience includes orthopedic surgeons specializing in sports medicine and knee injuries, as well as patients with ACL tears seeking a less invasive treatment option.
Features
- Biological scaffold made from bovine collagen designed to promote tissue regeneration.
- Facilitates healing of the torn ACL by bridging the gap between torn ends.
- Utilizes the patient's own blood to create a clot within the scaffold, stimulating the healing process.
- Implant is gradually resorbed and replaced by the patient's own ACL tissue.
- Designed to restore native knee biomechanics and function.
- Less invasive compared to traditional ACL reconstruction techniques.